May 27, 2026
Cell and gene therapy (CGT) manufacturing represents one of the most transformative shifts in modern medicine, redefining how diseases are treated at their root cause rather than merely managing symptoms. Unlike conventional pharmaceuticals, these therapies involve the modification or utilization of living cells or...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper